Oxidative Stress Tests Could Help Diagnose Many Diseases Better
- Authors
- Jeroen Frijhoff, Paul G. Winyard, Neven Zarkovic, Sean S. Davies, Roland Stocker, David Cheng, Annie R. Knight, Emma Louise Taylor, Jeannette Oettrich, Tatjana Ruskovska, Ana Cipak Gasparovic, Antonio Cuadrado, Daniela Weber, Henrik Enghusen Poulsen, Tilman Grune, Harald H.H.W. Schmidt, Pietro Ghezzi
- Journal
- Antioxidants & Redox Signaling
- Year
- 2015
- DOI
- 10.1089/ars.2015.6317
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- Netherlands
- Health Condition
- Cancer
- Body System
- Cardiovascular
TL;DR
Scientists found ways to measure "oxidative stress" (basically when your body gets damaged by harmful molecules) in different diseases, but there's no single perfect test that works for everything—they need to test these measurements more carefully and pick the right one for each specific disease before doctors can use them in real life.
Summary
Researchers analyzed the clinical potential of oxidative stress biomarkers - laboratory tests that measure damage to DNA, proteins, and fats caused by harmful molecules called free radicals. These biomarkers appear in virtually all diseases and could serve as valuable diagnostic tools. However, the review found significant challenges including inconsistent testing methods, small study sizes, and lack of standardization across different diseases. While promising, these tests need larger validation studies and comparison with current diagnostic standards before becoming routine clinical practice. The diversity of oxidative stress patterns across diseases means doctors would need different biomarker combinations for different conditions.
Abstract (excerpt)
Significance: Oxidative stress is considered to be an important component of various diseases. A vast number of methods have been developed and used in virtually all diseases to measure the extent and nature of oxidative stress, ranging from oxidation of DNA to proteins, lipids, and free amino…